Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus.
Zilli T, Achard V, Dal Pra A, Schmidt-Hegemann N, Jereczek-Fossa BA, Lancia A, Ingrosso G, Alongi F, Aluwini S, Arcangeli S, Blanchard P, Conde Moreno A, Couñago F, Créhange G, Dirix P, Gomez Iturriaga A, Guckenberger M, Pasquier D, Sargos P, Scorsetti M, Supiot S, Tree AC, Zapatero A, Le Guevelou J, Ost P, Belka C. Zilli T, et al. Among authors: gomez iturriaga a. Radiother Oncol. 2022 Nov;176:199-207. doi: 10.1016/j.radonc.2022.10.005. Epub 2022 Oct 10. Radiother Oncol. 2022. PMID: 36228761 Free article.
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Among authors: gomez iturriaga a, gomez caamano a. Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):259-72. doi: 10.1016/j.rpor.2015.04.003. Epub 2015 May 30. Rep Pract Oncol Radiother. 2015. PMID: 26109913 Free PMC article. Review.
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Among authors: gomez iturriaga a, gomez caamano a. Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):90-2. doi: 10.1016/j.rpor.2015.06.006. Epub 2015 Jul 20. Rep Pract Oncol Radiother. 2016. PMID: 26900365 Free PMC article.
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Cacicedo J, Navarro A, Del Hoyo O, Gomez-Iturriaga A, Alongi F, Medina JA, Elicin O, Skanjeti A, Giammarile F, Bilbao P, Casquero F, de Bari B, Dal Pra A. Cacicedo J, et al. Among authors: gomez iturriaga a. Br J Radiol. 2016 Nov;89(1067):20160217. doi: 10.1259/bjr.20160217. Epub 2016 Aug 2. Br J Radiol. 2016. PMID: 27416996 Free PMC article. Review.
High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions.
Nagore G, Lopez Guerra JL, Krumina E, Lagos M, Ovalles B, Miró A, Beltran L, Gómez E, Praena-Fernandez JM, Del Campo ER, Azinovic I, Gomez-Iturriaga A. Nagore G, et al. Among authors: gomez iturriaga a, gomez e. Radiother Oncol. 2018 May;127(2):219-224. doi: 10.1016/j.radonc.2018.03.022. Epub 2018 Apr 3. Radiother Oncol. 2018. PMID: 29625808
Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain.
Couñago F, Sancho G, Gómez-Iturriaga A, Henríquez I; Urological Tumours Working Group of the Spanish Society of Radiation Oncology (URONCOR/SEOR). Couñago F, et al. Among authors: gomez iturriaga a. Clin Transl Oncol. 2018 Nov;20(11):1484-1491. doi: 10.1007/s12094-018-1919-z. Epub 2018 Jul 10. Clin Transl Oncol. 2018. PMID: 29992463
Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology.
Gómez-Caamaño A, González-San Segundo C, Henríquez I, Maldonado X, Zapatero A; Expert Panel for the Consensus on Management of Castration-Resistant Prostate Cancer 2017, Urological Tumours Working Group (URONCOR), Spanish Society of Radiation Oncology (SEOR). Gómez-Caamaño A, et al. Clin Transl Oncol. 2019 Apr;21(4):420-432. doi: 10.1007/s12094-018-1940-2. Epub 2018 Oct 6. Clin Transl Oncol. 2019. PMID: 30293231
Oligometastatic prostate cancer: The game is afoot.
Lancia A, Zilli T, Achard V, Dirix P, Everaerts W, Gomez-Iturriaga A, Ingrosso G, Liefhooghe N, Miralbell R, Siva S, Van der Eecken K, Ost P. Lancia A, et al. Among authors: gomez iturriaga a. Cancer Treat Rev. 2019 Feb;73:84-90. doi: 10.1016/j.ctrv.2019.01.005. Epub 2019 Jan 17. Cancer Treat Rev. 2019. PMID: 30684842 Review.
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT.
Gomez-Iturriaga A, Casquero Ocio F, Ost P, Fernandez I, Rodeño E, Llarena R, Garcia-Olaverri J, Ortiz de Zarate R, Cacicedo J, Ahtamon A, Bilbao P. Gomez-Iturriaga A, et al. Eur J Cancer Care (Engl). 2019 Sep;28(5):e13093. doi: 10.1111/ecc.13093. Epub 2019 May 21. Eur J Cancer Care (Engl). 2019. PMID: 31115124
67 results